LIFR Polyklonale Antilichaam

Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells.

SWS; SJS2; STWS; CD118; LIF-R; Leukemia inhibitory factor receptor; LIF receptor; LIFR

3977

O70535

Extracellular, Cell membrane

Human, Mouse, Rat

451-580/1093

LIFR

Unconjugated

KLH conjugated synthetic peptide derived from rat LIFR

WB, ELISA, FCM, IHC-P, IHC-F, IF (IHC-P), IF (IHC-F), IF (ICC)

Purified by Protein A.

1µg/µl

WB (1:300-5000), ELISA (1:500-1000), FCM (1:20-100), IHC-P (1:200-400), IHC-F (1:100-500), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)

0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Unmodified

Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

3977

Dog, Cow